The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.
about
Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulationHuman cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscleComparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cellsCpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cellsThe lac operator-repressor system is functional in the mouseHuman cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection.Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccineReactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB.DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination.Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.Efficient production of germline transgenic chickens using lentiviral vectorsEndogenous Myc maintains the tumor microenvironment.Production of transgenic pigs mediated by pseudotyped lentivirus and spermIrradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging.Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter.Cre-mediated gene deletion in the mammary gland.Modelling Myc inhibition as a cancer therapy.High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung.A comparative analysis of constitutive promoters located in adeno-associated viral vectors.pTOM, a vector for expressing two proteins in mammalian cells.Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic miceThe enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.Characterization of the Promoter Regions of Two Sheep Keratin-Associated Protein Genes for Hair Cortex-Specific Expression.In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment.Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway.Optimization and delivery of plasmid DNA for vaccination.Transgenic mouse with the herpes simplex virus type 1 latency-associated gene: expression and function of the transgeneMatrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice.Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells.Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Transgenic animals in toxicology.A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells.The human ubiquitin C promoter directs high ubiquitous expression of transgenes in miceDNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.Identification and functional characterization of an aggregation domain in long myosin light chain kinase.DNA-binding of the Tet-transactivator curtails antigen-induced lymphocyte activation in mice.MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice.Ubiquitous and uniform in vivo fluorescence in ROSA26-EGFP BAC transgenic mice.
P2860
Q24683914-EDB7404C-2E2A-4190-B9BE-CA142C1B4DC8Q24795634-6DE5C743-012A-499E-A3D5-8D471A814A16Q24804883-8DCF8188-5A2B-46B3-97C3-5CB04F046944Q24810875-D3287893-B8FE-4ECE-BEC5-86DB8A3FF266Q28366874-B6FA0FA6-61B8-4F19-8B96-2B77886C0570Q30503430-D915E85A-A328-47CD-8E55-CF3EC6CF27EFQ30826113-E0819391-E29B-44F2-9BC0-710B5DB9F555Q33434415-E43E31BB-6EBE-4293-888F-D58C9D7D6496Q33781921-A7C02EC6-5AC6-4D79-9EEF-842B1C3A593DQ33784641-DD04EE48-2813-443D-9107-9D17806059D5Q33844440-38C56716-EA1C-477B-975B-32A43B37CADBQ34166132-844887A3-BE68-45F5-ABC1-1E87240FC741Q34177033-FAEDCD16-E0FD-4F93-9E71-D41E2B2C750EQ34247223-7096CD48-709D-4B22-B0B9-9245E2B18A22Q34500991-B772F6D1-7D2A-425A-AEA6-EDD8E02C7374Q34612904-27F3ED34-A337-4A84-99DF-B626A26D60BEQ34640577-AA275911-6DAF-4D59-9E6B-1A590002AE6DQ34811008-9730F9C0-3694-411D-B4D8-BD3B06899D75Q34845196-C3F28C04-4C7F-4DF0-B8BB-4BC4718159D9Q35234995-93D73565-2D21-4026-ACA2-8F19C5682AA9Q35401064-9EE59C3E-5DE9-4BF2-954D-D4431B108A91Q35778832-4C875BA8-68DE-431F-B133-9851D7C1BC54Q35786286-2DB1C633-B303-4C98-BCED-9BF73B49D43CQ35860573-DEDE1CFE-D558-43F5-A98E-EA6B26A04EB9Q35995784-444C01F3-774B-43E2-AA6C-7D6AB497E01EQ36299641-A6879BED-DD2C-407E-95BB-C3F23905FED6Q36685199-D87F2792-97BF-44D0-8FDA-D0BE71EE04C4Q36690285-18BD5A45-E7CA-45B4-9B56-54AD282529BEQ37059659-B5B32F25-D9E6-4AD0-9924-F6853613A6D9Q37128623-D905BC64-5561-4C2C-A72F-EBBABA98F4C6Q37170111-EF9CFFEB-9BAD-4694-B459-342C664EE37CQ37303897-4059608F-CB43-49C6-BDED-99BD3A678CABQ38050379-A0F0CBF2-3E0C-4B75-B03A-E215B2D6400EQ39578448-DB70F2BB-9FA5-4D91-89EF-38A83B966EE8Q39716227-980EB90B-6336-4F24-8C11-FA594D07B599Q39869845-2CB7442F-0B9D-414A-BC99-C9CC1A7C8193Q39993652-3747530E-C884-4796-9476-583035AFF71BQ42380157-48D1C966-A926-48FC-BBD5-B04E0C65244DQ42468494-F171299F-F667-4F51-93E0-97583AE313C8Q42773641-01E80E91-9493-47F5-94BE-5D3E8B359CB3
P2860
The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
The variability in activity of ...... r/promoter in transgenic mice.
@ast
The variability in activity of ...... r/promoter in transgenic mice.
@en
type
label
The variability in activity of ...... r/promoter in transgenic mice.
@ast
The variability in activity of ...... r/promoter in transgenic mice.
@en
prefLabel
The variability in activity of ...... r/promoter in transgenic mice.
@ast
The variability in activity of ...... r/promoter in transgenic mice.
@en
P2093
P2860
P356
P1476
The variability in activity of ...... r/promoter in transgenic mice.
@en
P2093
P2860
P304
P356
10.1093/NAR/19.22.6205
P407
P577
1991-11-01T00:00:00Z